US approves new trial of embryonic stem cells on blindness
(AFP)
AFP - US biotech company Advanced Cell Technology said Monday it was cleared by the government to start its second trial using human embryonic stem cells to treat blindness, this time in older people.
Keine Kommentare:
Kommentar veröffentlichen